TITCK-2024-0076-V376

Type II variation for application TITCK-2024-0076. Type II variation: Formulation Change for Retinavab — minor update

Variation Number
TITCK-2024-0076-V376
Type
Type II
Application
TITCK-2024-0076
Change
CHG-2021-0076
Status
Active
Fee
€23,016
Submitted
—
Approved
—
Description

Type II variation: Formulation Change for Retinavab — minor update